Israel Claims Targeted Iranian Facility Was Used for Chemical Weapons Development

Tel Aviv. Israel has claimed that the facility destroyed in its strike was not used for pharmaceutical production but for chemical weapons development. Iran has denied these allegations, labeling the strike an attack on civilian infrastructure.

On Tuesday, Israel alleged that Iran had targeted its cancer drug manufacturing facility. 

According to the Israeli military, the Tofigh Darou Research and Engineering Company, while operating outwardly as a pharmaceutical manufacturer, was internally conducting research related to chemical warfare materials.

The company is also accused of supplying substances like fentanyl to the Organization of Defensive Innovation and Research (SPND), an entity linked to Iran's nuclear program.

Israel stated that the facility was targeted because it served as a site for military activities under the guise of a civilian company. However, Iranian Foreign Minister Abbas Araghchi rejected Israel's claims, describing the attack as an open and shameful bombing of a pharmaceutical company.

He strongly criticized the action, calling it a violation of international law.